ArticleInternational journal of legal medicine2025
Poisoning suicide due to paroxetine overdose toxicity aided by benzodiazepine and antipsychotic drugs.
Article in International journal of legal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-marketing safety evaluation of paroxetine: a real-world pharmacovigilance analysis based on the FDA adverse event reporting system.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This contribution presents a case of suicide death due to ingestion of paroxetine in overdose by a 22-year-old psychiatric patient. The deceased was found dead in his room with blood exiting his nose and dry bloodstains on his left wrist. Many empty and semi-empty packets of prescribed medications were found in the scene. On internal examination, the urinary bladder was markedly distended, and the organs showed autolytic changes with no other macroscopic pathological lesions. Blood (from the left external iliac vein), urine, and gastric contents were sampled for toxicological analysis. The toxicological screening revealed the presence of the antidepressant selective serotonin reuptake inhibitor (SSRI) paroxetine, the benzodiazepine alprazolam and its metabolite alpha-hydroxy-alprazolam, and the antipsychotic quetiapine in blood, urine, and gastric contents, and the presence of nor-clozapine in urine. Quantitative analysis showed lethal blood paroxetine concentration of 3.3 mg/L and 1.58 mg/L in urine. Based on the medicolegal autopsy, the medical history, the circumstances of death by the police, the toxicological results and the pharmacology of the involved drugs, the manner and cause of death were recorded as suicide and, mixed-drug intoxication due to the synergistic action of the primary toxicant paroxetine and the secondary contribution of alprazolam, quetiapine and clozapine, respectively. It was classified as X61 in International Classification of Diseases (10th revision). This is the first fatal case reporting the simultaneous presence of antipsychotics (quetiapine and clozapine) and benzodiazepines (alprazolam) with toxic paroxetine levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.